Trial Profile
Use of bevacizumab in a real-life setting in France: ETNA study.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Oct 2017
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms ETNA
- 31 Oct 2017 New trial record